Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.

被引：0
|
作者：
Lowry, Kathryn P.
Geuzinge, H. Amarens
Stout, Natasha K.
Alagoz, Oguzhan
Hampton, John M.
Kerlikowske, Karla
Miglioretti, Diana L.
Schecter, Clyde
Sprague, Brian L.
Trentham-Dietz, Amy
Tosteson, Anna N. A.
Van Ravesteyn, Nicolien
Yaffe, Martin
Yeh, Jennifer
Couch, Fergus
Kraft, Peter
Polley, Eric
Mandelblatt, Jeanne S.
Kurian, Allison W.
Robson, Mark E.
机构：
[1] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[2] Erasmus MC, Rotterdam, Netherlands
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[5] Univ Wisconsin, Madison, WI USA
[6] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
[8] Univ Calif Davis, Sch Med, Davis, CA USA
[9] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[10] Univ Vermont, Burlington, VT USA
[11] Geisel Sch Med, Lebanon, NH USA
[12] Boston Childrens Hosp, Boston, MA USA
[13] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[14] Mayo Clin, Harvard Sch Publ Hlth, Rochester, MN USA
[15] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[16] Stanford Sch Med, Stanford, CA 94305 USA
[17] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10500
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Meta-analysis of breast cancer risk for individuals with PALB2 pathogenic variants
    Ruberu, Thanthirige L. M.
    Braun, Danielle
    Parmigiani, Giovanni
    Biswas, Swati
    GENETIC EPIDEMIOLOGY, 2024, 48 (08) : 448 - 454
  • [32] Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
    Toss, Angela
    Tenedini, Elena
    Piombino, Claudia
    Venturelli, Marta
    Marchi, Isabella
    Gasparini, Elisa
    Barbieri, Elena
    Razzaboni, Elisabetta
    Domati, Federica
    Caggia, Federica
    Grandi, Giovanni
    Combi, Francesca
    Tazzioli, Giovanni
    Dominici, Massimo
    Tagliafico, Enrico
    Cortesi, Laura
    GENES, 2021, 12 (05)
  • [33] Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
    Woodward, Emma R.
    van Veen, Elke M.
    Forde, Claire
    Harkness, Elaine F.
    Byers, Helen J.
    Ellingford, Jamie M.
    Burghel, George J.
    Schlech, Helene
    Bowers, Naomi L.
    Wallace, Andrew J.
    Howell, Sacha J.
    Howell, Anthony
    Lalloo, Fiona
    Newman, William G.
    Smith, Miriam J.
    Gareth Evans, D.
    GENETICS IN MEDICINE, 2021, 23 (10) : 1969 - 1976
  • [34] "I wish that there was more info": characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants
    Reyes, Kathryn G.
    Clark, Cheyla
    Gerhart, Meredith
    Newson, Ainsley J.
    Ormond, Kelly E.
    FAMILIAL CANCER, 2022, 21 (02) : 143 - 155
  • [35] Frequency of large rearrangements in BRCA1, BRCA2, ATM, CHEK2, and PALB2 in hereditary cancer testing
    Bissonnette, J.
    Doonanco, K.
    Xu, Z.
    Klein, R. T.
    Hruska, K. S.
    CANCER RESEARCH, 2016, 76
  • [36] “I wish that there was more info”: characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants
    Kathryn G. Reyes
    Cheyla Clark
    Meredith Gerhart
    Ainsley J. Newson
    Kelly E. Ormond
    Familial Cancer, 2022, 21 : 143 - 155
  • [37] High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Irene Rainville
    Shanell Hatcher
    Eric Rosenthal
    Katie Larson
    Ryan Bernhisel
    Stephanie Meek
    Heidi Gorringe
    Erin Mundt
    Susan Manley
    Breast Cancer Research and Treatment, 2020, 180 : 503 - 509
  • [38] Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations
    Hoste, G.
    D'Hoore, P.
    Legius, E.
    Van Buggenhout, G.
    Floris, G.
    Wildiers, H.
    Han, S. N.
    Van Nieuwenhuysen, E.
    Berteloot, P.
    Smeets, A.
    Nevelsteen, I.
    Weltens, C.
    Janssen, H.
    Van Limbergen, E.
    Neven, P.
    Punie, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [39] Molecular analysis of breast cancers from individuals with hereditary cancer syndromes secondary to mutations in BRCA1, BRCA2, ATM, CHEK2, and PALB2
    Blum, Joanne L.
    Wong, Shukmei
    Pearson, Edward J.
    Nair, Anju
    Snipes, George J.
    Briones, Natalia
    Baker, Angela
    Cropp, Cheryl D.
    Carpten, John D.
    CANCER RESEARCH, 2018, 78 (04)
  • [40] High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Rainville, Irene
    Hatcher, Shanell
    Rosenthal, Eric
    Larson, Katie
    Bernhisel, Ryan
    Meek, Stephanie
    Gorringe, Heidi
    Mundt, Erin
    Manley, Susan
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 503 - 509
12345